Bristol-Myers Squibb Co (NYSE:BMY)
| 50.16 Delayed Data As of Dec 07 |  +0.28 / +0.56%Today’s Change | 48.25 Today|||52-Week Range 80.67 | -30.28% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 49.88 |
| Today’s open | 50.33 |
| Day’s range | 50.00 - 51.00 |
| Volume | 14,710,574 |
| Average volume (3 months) | 12,569,793 |
| Market cap | $101.9B |
Data as of 4:00pm ET, 12/07/2023
Growth & Valuation
| Earnings growth (last year) | -5.67% |
| Earnings growth (this year) | +3.78% |
| Earnings growth (next 5 years) | -0.37% |
| Revenue growth (last year) | -0.49% |
| P/E ratio | 12.7 |
| Price/Sales | 3.35 |
| Price/Book | 3.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | +0.33 | +0.09% |
| REGNRegeneron Pharmaceut... | +13.64 | +1.63% |
| SNYSanofi | +0.09 | +0.20% |
| ZTSZoetis Inc | -0.22 | -0.12% |
Data as of 4:00pm ET, 12/07/2023
Financials
| Next reporting date | February 2, 2024 |
| EPS forecast (this quarter) | $1.95 |
| Annual revenue (last year) | $46.2B |
| Annual profit (last year) | $6.3B |
| Net profit margin | 13.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Princeton, New Jersey |
Forecasts
